Rhythmic Sensory Stimulation on Fibromyalgia

An Investigation of the Effects of Rhythmic Sensory Stimulation on Fibromyalgia

NCT06416826•Women's College Hospital

Summary

The aim of this project is to further examine the effectiveness of Rhythmic Sensory Stimulation (RSS) with low-frequency sounds and somatosensory stimulation as a complementary therapy for fibromyalgia, and to investigate potential mechanisms underlying the effects of RSS on chronic pain.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•patients with clinical diagnosis of fibromyalgia
•able to read and write English adequately
•have satisfactory hearing bilaterally (self-reported)
•have the ability to operate the supplied device

Exclusion Criteria

•acute and active inflammatory conditions (e.g., rheumatoid arthritis, osteoarthritis, autoimmune disease)
•medical or psychiatric illness
•history of psychosis, epilepsy, seizures
•pregnancy or breast feeding
•hemorrhaging or active bleeding
•thrombosis, angina pectoris
•heart disease, such as hypotension, arrhythmia, pacemaker
•substance abuse (harmful or hazardous use of psychoactive subtances, including alcohol and illicit drugs) in the last year
•suffering from a recently prolapsed vertebral disc
•recovering from a recent accident with back or neck injury.

Key Dates

Start Date

April 1, 2019

Primary Completion Date

March 1, 2020

Completion Date

March 1, 2020

Last Updated

May 16, 2024

Conditions

Chronic Pain, Widespread

Interventions

Vibroacoustic Therapy System - VTS 1000

DEVICE

Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents

NCT06929598

Chronic PainChronic Pain Syndrome+6 more

View study

COMPLETEDNA

Effects of Acute Exercise on Pain and Human Movement

NCT03882333

Chronic Musculoskeletal DiseaseChronic Pain, Widespread

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 16, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions